Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership8,535,918 shares
Latest Disclosed Value $ 123,452,195
Geode Capital Management, Llc reports 16.21% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 8,535,918 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $123,429,374 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 7,345,267 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 16.21% during the quarter. The current value of the position is $123,685,452 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTICS COM 03152W109 8,535,918 1,190,651 16.21 123,452 18.01 0.0041
2026-02-09 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 7,345,267 246,174 3.47 104,616 86.98 0.0065
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 7,099,093 392,604 5.85 55,951 45.58 0.0036
2025-08-08 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,706,489 -57,278 -0.85 38,434 -30.38 0.0027
2025-05-13 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 6,763,767 152,835 2.31 55,204 -11.37 0.0043
2025-02-12 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 6,610,932 11,061 0.17 62,289 -11.65 0.0048
2024-11-12 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 6,599,871 80,926 1.24 70,499 9.00 0.0057
2024-08-09 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,518,945 308,209 4.96 64,680 -11.61 0.0057
2024-05-13 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 6,210,736 259,441 4.36 73,173 -13.36 0.0068
2024-02-13 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 5,951,295 345,129 6.16 84,458 23.88 0.0088
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 5,606,166 210,560 3.90 68,179 0.61 0.0081
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 5,395,606 253,199 4.92 67,769 18.83 0.0080
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 5,142,407 251,979 5.15 57,029 96,559.32 0.0074
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 4,890,428 167,542 3.55 60 -99.88 0.0084
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 4,722,886 63,632 1.37 49,306 -1.47 0.0075
2022-08-12 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 4,659,254 143,003 3.17 50,040 17.00 0.0073
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,516,251 -210,482 -4.45 42,768 -21.66 0.0053
2022-02-11 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 4,726,733 275,911 6.20 54,593 28.44 0.0066
2021-11-12 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 4,450,822 -195,109 -4.20 42,505 -5.09 0.0057
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 4,645,931 270,704 6.19 44,786 3.61 0.0062
2021-05-12 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,375,227 316,124 7.79 43,227 -53.88 0.0066
2021-02-12 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 4,059,103 219,012 5.70 93,724 72.85 0.0157
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,840,091 -33,299 -0.86 54,222 -7.17 0.0106
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,873,390 63,555 1.67 58,410 65.93 0.0125
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,809,835 303,764 8.66 35,202 3.08 0.0092
2020-02-20 2019-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 3,506,071 146,857 4.37 34,149 26.76 0.0071
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,506,071 146,857 34,149 4,351.9906
2019-11-12 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,359,214 182,723 5.75 26,940 -32.04 0.0063
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,176,491 452,284 16.60 39,642 7.00 0.0096
2019-05-14 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,724,207 540,528 24.75 37,049 77.11 0.0096
2019-03-06 2018-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,183,679 180,938 9.03 20,919 -13.60 0.0065
2019-02-13 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,183,679 180,938 20,919
2018-11-13 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,002,741 81,299 4.23 24,213 -19.32 0.0068
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,921,442 179,629 10.31 30,012 14.57 0.0092
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,741,813 175,552 11.21 26,196 16.23 0.0085
2018-02-13 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,566,261 93,172 6.32 22,538 1.46 0.0077
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,473,089 222,064 17.75 22,214 76.34 0.0082
2017-08-14 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,251,025 83,669 7.17 12,597 51.35 0.0050
2017-06-21 2017-03-31 13F/A-1 AMICUS THERAPEUTICS INC-REDH COM 03152W109 1,167,356 52,003 4.66 8,323 50.15 0.0034
2017-05-12 2017-03-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 1,167,356 8,323
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 1,115,353 46,004 4.30 5,543 -29.95 0.0026
2016-11-10 2016-09-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 1,069,349 212,602 24.82 7,913 69.19 0.0040
2016-08-12 2016-06-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 856,747 15,290 1.82 4,677 -34.22 0.0025
2016-05-13 2016-03-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 841,457 33,449 4.14 7,110 -9.28 0.0038
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 808,008 58,610 7.82 7,837 -25.25 0.0045
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 749,398 48,142 6.87 10,484 5.66 0.0064
2015-08-14 2015-06-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 701,256 293,525 71.99 9,922 123.67 0.0057
2015-05-14 2015-03-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 407,731 10,283 2.59 4,436 34.18 0.0025
2015-02-12 2014-12-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 397,448 151,867 61.84 3,306 126.28 0.0020
2014-11-14 2014-09-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 245,581 107,907 78.38 1,461 218.30 0.0009
2014-08-13 2014-06-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 137,674 -22,406 -14.00 459 38.67 0.0003
2014-05-14 2014-03-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 160,080 4,976 3.21 331 -9.07 0.0002
2014-02-14 2013-12-31 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 155,104 2,985 1.96 364 3.12 0.0003
2013-11-14 2013-09-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 152,119 3,619 2.44 353 2.02 0.0003
2013-08-14 2013-06-30 13F AMICUS THERAPEUTICS INC-REDH COM 03152W109 148,500 148,500 346 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.